| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ankyrin binding | 3.49e-07 | 23 | 52 | 4 | GO:0030506 | |
| GeneOntologyMolecularFunction | actin filament binding | 3.06e-04 | 227 | 52 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.65e-04 | 130 | 52 | 4 | GO:0005200 | |
| GeneOntologyBiologicalProcess | inflammatory response to wounding | 2.12e-06 | 38 | 50 | 4 | GO:0090594 | |
| GeneOntologyBiologicalProcess | wound healing involved in inflammatory response | 3.77e-06 | 13 | 50 | 3 | GO:0002246 | |
| GeneOntologyBiologicalProcess | actin filament capping | 4.62e-06 | 46 | 50 | 4 | GO:0051693 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 7.59e-06 | 52 | 50 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | microglia differentiation | 1.07e-05 | 18 | 50 | 3 | GO:0014004 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 1.35e-05 | 60 | 50 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 1.44e-05 | 61 | 50 | 4 | GO:0030834 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 1.97e-05 | 66 | 50 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of actin filament polymerization | 3.27e-05 | 75 | 50 | 4 | GO:0030837 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 3.74e-05 | 156 | 50 | 5 | GO:0030833 | |
| GeneOntologyBiologicalProcess | dendritic cell chemotaxis | 4.68e-05 | 29 | 50 | 3 | GO:0002407 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.41e-05 | 89 | 50 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 6.82e-05 | 177 | 50 | 5 | GO:0008064 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polymerization | 6.99e-05 | 91 | 50 | 4 | GO:0032272 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | 7.08e-05 | 426 | 50 | 7 | GO:0032535 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 7.38e-05 | 180 | 50 | 5 | GO:0030832 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 8.43e-05 | 438 | 50 | 7 | GO:0032970 | |
| GeneOntologyBiologicalProcess | dendritic cell migration | 9.05e-05 | 36 | 50 | 3 | GO:0036336 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 9.53e-05 | 190 | 50 | 5 | GO:0030041 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.01e-04 | 100 | 50 | 4 | GO:0043242 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | 1.04e-04 | 312 | 50 | 6 | GO:0002573 | |
| GeneOntologyBiologicalProcess | tolerance induction to self antigen | 1.20e-04 | 7 | 50 | 2 | GO:0002513 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.22e-04 | 105 | 50 | 4 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 1.67e-04 | 489 | 50 | 7 | GO:0043254 | |
| GeneOntologyBiologicalProcess | multicellular organismal-level homeostasis | TGFB1 HDAC3 TLR4 VPS13A TRPM8 CCR7 GPR183 HMOX1 DYNC1H1 TNFRSF11B | 1.69e-04 | 1043 | 50 | 10 | GO:0048871 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 1.97e-04 | 222 | 50 | 5 | GO:0008154 | |
| GeneOntologyBiologicalProcess | positive regulation of transport | 2.26e-04 | 1081 | 50 | 10 | GO:0051050 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.37e-04 | 231 | 50 | 5 | GO:0032271 | |
| GeneOntologyBiologicalProcess | interleukin-23 production | 2.56e-04 | 10 | 50 | 2 | GO:0032627 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-23 production | 2.56e-04 | 10 | 50 | 2 | GO:0032667 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | 3.19e-04 | 384 | 50 | 6 | GO:0032956 | |
| GeneOntologyBiologicalProcess | chemokine production | 3.20e-04 | 135 | 50 | 4 | GO:0032602 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 4.09e-04 | 144 | 50 | 4 | GO:0051261 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 4.09e-04 | 144 | 50 | 4 | GO:0043244 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 4.64e-04 | 579 | 50 | 7 | GO:0051493 | |
| GeneOntologyBiologicalProcess | regulation of cold-induced thermogenesis | 5.02e-04 | 152 | 50 | 4 | GO:0120161 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 5.02e-04 | 152 | 50 | 4 | GO:1904035 | |
| GeneOntologyBiologicalProcess | cold-induced thermogenesis | 5.53e-04 | 156 | 50 | 4 | GO:0106106 | |
| GeneOntologyBiologicalProcess | positive regulation of chemokine (C-X-C motif) ligand 2 production | 5.93e-04 | 15 | 50 | 2 | GO:2000343 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 6.37e-04 | 162 | 50 | 4 | GO:0030316 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 6.81e-04 | 291 | 50 | 5 | GO:0032984 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 6.84e-04 | 618 | 50 | 7 | GO:0090066 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production | 6.86e-04 | 444 | 50 | 6 | GO:0001818 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte cytokine production | 7.11e-04 | 72 | 50 | 3 | GO:0061082 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 7.81e-04 | 300 | 50 | 5 | GO:0110053 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex assembly | 8.15e-04 | 173 | 50 | 4 | GO:0031333 | |
| GeneOntologyBiologicalProcess | phospholipid homeostasis | 8.60e-04 | 18 | 50 | 2 | GO:0055091 | |
| GeneOntologyBiologicalProcess | macrophage differentiation | 8.64e-04 | 77 | 50 | 3 | GO:0030225 | |
| GeneOntologyBiologicalProcess | adaptive thermogenesis | 8.69e-04 | 176 | 50 | 4 | GO:1990845 | |
| GeneOntologyCellularComponent | spectrin | 3.92e-09 | 9 | 51 | 4 | GO:0008091 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 1.14e-06 | 9 | 51 | 3 | GO:0014731 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 7.82e-05 | 93 | 51 | 4 | GO:0030864 | |
| GeneOntologyCellularComponent | cell cortex | 2.76e-04 | 371 | 51 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.76e-04 | 129 | 51 | 4 | GO:0030863 | |
| GeneOntologyCellularComponent | axolemma | 1.19e-03 | 21 | 51 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | cell surface | 1.32e-03 | 1111 | 51 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | main axon | 1.34e-03 | 89 | 51 | 3 | GO:0044304 | |
| MousePheno | renal tubular necrosis | 3.68e-07 | 21 | 41 | 4 | MP:0004154 | |
| MousePheno | renal necrosis | 1.65e-06 | 30 | 41 | 4 | MP:0003946 | |
| MousePheno | decreased dendritic cell number | 5.67e-05 | 72 | 41 | 4 | MP:0008127 | |
| Domain | Spectrin_bsu | 5.34e-11 | 4 | 52 | 4 | IPR016343 | |
| Domain | Actinin_actin-bd_CS | 4.55e-07 | 23 | 52 | 4 | IPR001589 | |
| Domain | Spectrin | 4.55e-07 | 23 | 52 | 4 | PF00435 | |
| Domain | ACTININ_2 | 4.55e-07 | 23 | 52 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.55e-07 | 23 | 52 | 4 | PS00019 | |
| Domain | Spectrin_repeat | 1.21e-06 | 29 | 52 | 4 | IPR002017 | |
| Domain | PH_dom-spectrin-type | 1.69e-06 | 9 | 52 | 3 | IPR001605 | |
| Domain | Spectrin/alpha-actinin | 1.81e-06 | 32 | 52 | 4 | IPR018159 | |
| Domain | SPEC | 1.81e-06 | 32 | 52 | 4 | SM00150 | |
| Domain | CH | 3.19e-05 | 65 | 52 | 4 | SM00033 | |
| Domain | CH | 4.28e-05 | 70 | 52 | 4 | PF00307 | |
| Domain | - | 4.52e-05 | 71 | 52 | 4 | 1.10.418.10 | |
| Domain | CH | 5.04e-05 | 73 | 52 | 4 | PS50021 | |
| Domain | CH-domain | 5.61e-05 | 75 | 52 | 4 | IPR001715 | |
| Domain | Ion_trans_dom | 3.94e-03 | 114 | 52 | 3 | IPR005821 | |
| Domain | Ion_trans | 3.94e-03 | 114 | 52 | 3 | PF00520 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.41e-08 | 10 | 42 | 4 | MM15112 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 2.95e-08 | 31 | 42 | 5 | M877 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 4.67e-06 | 38 | 42 | 4 | MM14969 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.24e-05 | 102 | 42 | 5 | M27648 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.78e-05 | 110 | 42 | 5 | MM15350 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.83e-05 | 121 | 42 | 5 | M872 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.57e-05 | 63 | 42 | 4 | M11187 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 4.83e-05 | 68 | 42 | 4 | MM14968 | |
| Pathway | WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE | 8.62e-05 | 5 | 42 | 2 | M46464 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 9.51e-05 | 156 | 42 | 5 | M27097 | |
| Pathway | REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY | 1.26e-04 | 33 | 42 | 3 | M27010 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.35e-04 | 168 | 42 | 5 | MM14785 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 2.22e-04 | 187 | 42 | 5 | M961 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | TGFB1 HDAC3 GTF2F2 ANO6 POLR2B TLR4 SUPT16H RNF213 NUP188 HMOX1 DYNC1H1 | 2.39e-04 | 1081 | 42 | 11 | M27548 |
| Pathway | WP_OPIOID_RECEPTOR_PATHWAYS | 2.42e-04 | 41 | 42 | 3 | M48338 | |
| Pathway | REACTOME_HIV_TRANSCRIPTION_ELONGATION | 2.79e-04 | 43 | 42 | 3 | M29569 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 2.99e-04 | 44 | 42 | 3 | M109 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 3.18e-04 | 202 | 42 | 5 | MM15650 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 3.64e-04 | 47 | 42 | 3 | MM15328 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.12e-04 | 49 | 42 | 3 | M41832 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 6.77e-04 | 58 | 42 | 3 | M805 | |
| Pathway | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX | 7.12e-04 | 59 | 42 | 3 | MM14504 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES | 8.23e-04 | 62 | 42 | 3 | M27618 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 9.82e-04 | 149 | 42 | 4 | M4076 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | 1.01e-03 | 888 | 42 | 9 | M48034 | |
| Pathway | WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS | 1.15e-03 | 17 | 42 | 2 | M39807 | |
| Pathway | REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME | 1.17e-03 | 70 | 42 | 3 | M27008 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 1.19e-03 | 157 | 42 | 4 | M4669 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 1.29e-03 | 18 | 42 | 2 | MM15334 | |
| Pathway | WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2 | 1.38e-03 | 74 | 42 | 3 | M45517 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR2_IIIA_TM | 1.43e-03 | 19 | 42 | 2 | M27739 | |
| Pathway | WP_ESTROGEN_SIGNALING | 1.54e-03 | 77 | 42 | 3 | MM15934 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 1.70e-03 | 293 | 42 | 5 | MM15120 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.79e-03 | 81 | 42 | 3 | M865 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS | 1.91e-03 | 83 | 42 | 3 | MM15314 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 2.08e-03 | 307 | 42 | 5 | M894 | |
| Pathway | REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | 2.11e-03 | 23 | 42 | 2 | M3630 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 2.36e-03 | 464 | 42 | 6 | M27547 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | 2.37e-03 | 630 | 42 | 7 | M11480 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 1.45e-09 | 11 | 52 | 4 | 17607528 | |
| Pubmed | 3.14e-09 | 13 | 52 | 4 | 18796539 | ||
| Pubmed | 3.15e-09 | 3 | 52 | 3 | 11294830 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 3.15e-09 | 3 | 52 | 3 | 32425157 | |
| Pubmed | Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. | 3.15e-09 | 3 | 52 | 3 | 23921128 | |
| Pubmed | 1.26e-08 | 4 | 52 | 3 | 21412925 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.34e-08 | 18 | 52 | 4 | 12119179 | |
| Pubmed | 3.15e-08 | 5 | 52 | 3 | 26784546 | ||
| Pubmed | Cell organization, growth, and neural and cardiac development require αII-spectrin. | 3.75e-07 | 10 | 52 | 3 | 22159418 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28840938 | ||
| Pubmed | TRESK K+ Channel Activity Regulates Trigeminal Nociception and Headache. | 2.19e-06 | 2 | 52 | 2 | 31308053 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18704924 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33962830 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 18234118 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21307647 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28346614 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 35702793 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20470885 | ||
| Pubmed | C-reactive protein promotes inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells. | 2.19e-06 | 2 | 52 | 2 | 31391207 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17277740 | ||
| Pubmed | Caspase-3/7-mediated Cleavage of β2-spectrin is Required for Acetaminophen-induced Liver Damage. | 2.19e-06 | 2 | 52 | 2 | 26884715 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29028772 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21216973 | ||
| Pubmed | The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma. | 2.19e-06 | 2 | 52 | 2 | 25880619 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27354342 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28627599 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 26176983 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17589347 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 17567933 | ||
| Pubmed | Utilization of spectrins βI and βIII in diagnosis of hepatocellular carcinoma. | 2.19e-06 | 2 | 52 | 2 | 30798076 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27220664 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 29973666 | ||
| Pubmed | Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. | 2.19e-06 | 2 | 52 | 2 | 8383238 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28817313 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25792017 | ||
| Pubmed | [Effect of lutein on relieving oxidative stress in mice induced by D-galatose]. | 2.19e-06 | 2 | 52 | 2 | 20726230 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23065289 | ||
| Pubmed | 5.38e-06 | 653 | 52 | 8 | 22586326 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 26745712 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 27853171 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25661467 | ||
| Pubmed | Microbiota-derived metabolite promotes HDAC3 activity in the gut. | 6.57e-06 | 3 | 52 | 2 | 32731255 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25086906 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21948984 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 12376363 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 34463846 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 15661045 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 28423042 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18827744 | ||
| Pubmed | High mobility group box 1 activates Toll like receptor 4 signaling in hepatic stellate cells. | 6.57e-06 | 3 | 52 | 2 | 22841886 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 15623538 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25423075 | ||
| Pubmed | Osteoprotegerin Expression in Liver is Induced by IL13 through TGFβ. | 6.57e-06 | 3 | 52 | 2 | 35060690 | |
| Pubmed | TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria. | 6.57e-06 | 3 | 52 | 2 | 19407153 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 20638132 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 31819138 | ||
| Pubmed | USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis. | 6.57e-06 | 3 | 52 | 2 | 29724812 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 23888080 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 25961925 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 27243216 | ||
| Pubmed | Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver. | 6.57e-06 | 3 | 52 | 2 | 35506565 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 28322133 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 21739671 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 31796867 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 8479293 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 24211974 | ||
| Pubmed | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 6.57e-06 | 3 | 52 | 2 | 21679949 | |
| Pubmed | Nodal β spectrins are required to maintain Na+ channel clustering and axon integrity. | 6.57e-06 | 3 | 52 | 2 | 32052742 | |
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 6.57e-06 | 3 | 52 | 2 | 1467942 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 22798246 | ||
| Pubmed | Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. | 7.08e-06 | 25 | 52 | 3 | 8493579 | |
| Pubmed | TPP2 NCAPG POLR2B SPTBN1 SPTBN2 SUPT16H PDCD11 RNF213 NUP188 EXTL3 DYNC1H1 | 7.46e-06 | 1440 | 52 | 11 | 30833792 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HDAC3 MYO1D USP11 POLR2B SUPT16H VPS13A PDCD11 RNF213 NUP188 DDX55 TTC3 | 1.07e-05 | 1496 | 52 | 11 | 32877691 |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | 1.23e-05 | 732 | 52 | 8 | 34732716 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21756853 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 30696809 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23521017 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 32298648 | ||
| Pubmed | TLR4 mediates LPS-induced HO-1 expression in mouse liver: role of TNF-alpha and IL-1beta. | 1.31e-05 | 4 | 52 | 2 | 12918124 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 22891325 | ||
| Pubmed | Loss of β2-spectrin prevents cardiomyocyte differentiation and heart development. | 1.31e-05 | 4 | 52 | 2 | 24064296 | |
| Pubmed | TLR4, rather than TLR2, regulates wound healing through TGF-β and CCL5 expression. | 1.31e-05 | 4 | 52 | 2 | 24252748 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 15004187 | ||
| Pubmed | SOCS3 promotes TLR4 response in macrophages by feedback inhibiting TGF-beta1/Smad3 signaling. | 1.31e-05 | 4 | 52 | 2 | 17920684 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21437904 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 19265160 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 1.31e-05 | 4 | 52 | 2 | 3862089 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 27481847 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 25239913 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 29335601 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 26238954 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 1.31e-05 | 4 | 52 | 2 | 12820899 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 25252690 | ||
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 26187182 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | GTF2F2 MYO1D RBM12B POLR2B SPTBN1 SPTBN2 SUPT16H PDCD11 DDX55 DYNC1H1 | 1.46e-05 | 1257 | 52 | 10 | 36526897 |
| Pubmed | 1.67e-05 | 33 | 52 | 3 | 12676794 | ||
| Pubmed | 2.19e-05 | 5 | 52 | 2 | 26432290 | ||
| Pubmed | RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages. | 2.19e-05 | 5 | 52 | 2 | 35463988 | |
| Pubmed | Regulation of B1 cell migration by signals through Toll-like receptors. | 2.19e-05 | 5 | 52 | 2 | 17060475 | |
| GeneFamily | EF-hand domain containing|Spectrins | 6.44e-10 | 7 | 39 | 4 | 1113 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.85e-04 | 206 | 39 | 4 | 682 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 8.91e-06 | 250 | 51 | 6 | M11318 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.18e-06 | 159 | 52 | 5 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.41e-06 | 184 | 52 | 5 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.82e-06 | 190 | 52 | 5 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-06 | 199 | 52 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-06 | 200 | 52 | 5 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.52e-05 | 169 | 52 | 4 | 17568e7aacfdcd96c469bae57d5ffad04954e9bd | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-05 | 173 | 52 | 4 | eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_8|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 179 | 52 | 4 | 163f5430d72ea0c1b239ea5d21e53be536636d3d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-05 | 182 | 52 | 4 | de15a77b8d3527638bea5b04e0b2af03ac93bc18 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 186 | 52 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.69e-05 | 187 | 52 | 4 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-05 | 188 | 52 | 4 | cb091912f9b627a78a8793a37df7f1de839f887f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-05 | 192 | 52 | 4 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-05 | 192 | 52 | 4 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.41e-05 | 192 | 52 | 4 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | control-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.72e-05 | 194 | 52 | 4 | a5284adca931a78b1c4592925c4860853ebd24f1 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.87e-05 | 195 | 52 | 4 | 028622b234551b185977fbee10c06851a45456a5 | |
| ToppCell | BAL-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 8.03e-05 | 196 | 52 | 4 | c32b7b7e6a4781c19c30c6e32d5563f82355deb0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.19e-05 | 197 | 52 | 4 | b72dc02b76a782f08eb1350ce131b072caec1ab0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.35e-05 | 198 | 52 | 4 | acb84681569651447d684aa3960f0510d7ff17e8 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.51e-05 | 199 | 52 | 4 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | wk_15-18-Hematologic-Myeloid-SPP1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.51e-05 | 199 | 52 | 4 | c7fc2ac1601346aac71e7620a8a440fde8d92dbd | |
| ToppCell | wk_08-11-Hematologic-Myeloid-SPP1+_Mac|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.51e-05 | 199 | 52 | 4 | d94cf750599366061066074e8007d707adf6fc5a | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD8+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 8.51e-05 | 199 | 52 | 4 | 6a1d84f61e1efaab541910926d6911122372659f | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 8.68e-05 | 200 | 52 | 4 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | wk_08-11-Hematologic-Myeloid|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.68e-05 | 200 | 52 | 4 | 148e09e27e4a563bdd1fbe9a593cd938885cbb1b | |
| Drug | ADPribulose | 1.70e-08 | 13 | 52 | 4 | CID000197570 | |
| Drug | dimethyl adipimidate | 6.34e-07 | 30 | 52 | 4 | CID000025738 | |
| Drug | phenylhydrazine | 1.22e-06 | 82 | 52 | 5 | CID000007516 | |
| Drug | plakin | 1.22e-06 | 82 | 52 | 5 | CID000018752 | |
| Drug | p-hydroxyphenylpyruvate | 2.05e-06 | 91 | 52 | 5 | CID000000979 | |
| Drug | 1,1'-azobis(N,N-dimethylformamide | 2.69e-06 | 173 | 52 | 6 | CID000004278 | |
| Drug | 2-nitro-5-thiocyanobenzoic acid | 4.37e-06 | 48 | 52 | 4 | CID000092266 | |
| Drug | MAPS | 4.76e-06 | 191 | 52 | 6 | CID000066161 | |
| Drug | PRODAN | 5.01e-06 | 15 | 52 | 3 | CID000028127 | |
| Drug | 6-propionyl-2-(dimethylamino)naphthalene | 6.16e-06 | 16 | 52 | 3 | CID000107729 | |
| Drug | dimyristoylphosphatidylcholine | 1.39e-05 | 64 | 52 | 4 | CID000026197 | |
| Drug | cocoa butter | 1.68e-05 | 22 | 52 | 3 | ctd:C052387 | |
| Drug | AC1L1HCM | 1.68e-05 | 22 | 52 | 3 | CID000004072 | |
| Drug | lipopolysaccharide, E. coli O26-B6 | 2.00e-05 | 145 | 52 | 5 | ctd:C433788 | |
| Drug | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2.20e-05 | 24 | 52 | 3 | ctd:C518860 | |
| Drug | zinc mesoporphyrin | 3.06e-05 | 4 | 52 | 2 | ctd:C058069 | |
| Drug | aristolactam | 3.06e-05 | 4 | 52 | 2 | CID000096710 | |
| Drug | AC1L1DDF | 3.20e-05 | 79 | 52 | 4 | CID000002302 | |
| Drug | Actinomycin C2 | 5.09e-05 | 5 | 52 | 2 | CID000122716 | |
| Drug | ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate | 6.40e-05 | 34 | 52 | 3 | ctd:C507035 | |
| Drug | baicalin | 7.61e-05 | 36 | 52 | 3 | ctd:C038044 | |
| Drug | Titanium | 7.61e-05 | 36 | 52 | 3 | ctd:D014025 | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 5880_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 5500_DN | |
| Drug | Sodium Cholate | 1.05e-04 | 40 | 52 | 3 | ctd:D020358 | |
| Drug | myrrh resin | 1.07e-04 | 7 | 52 | 2 | ctd:C587573 | |
| Drug | di-2-pyridyl ketone | 1.07e-04 | 7 | 52 | 2 | CID000088065 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 7.29e-12 | 4 | 50 | 4 | DOID:0050882 (implicated_via_orthology) | |
| Disease | lung disease (biomarker_via_orthology) | 2.88e-05 | 35 | 50 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | pathological myopia | 3.82e-05 | 111 | 50 | 4 | EFO_0004207 | |
| Disease | Inflammation | 6.47e-05 | 127 | 50 | 4 | C0021368 | |
| Disease | Fibrosis | 8.48e-05 | 50 | 50 | 3 | C0016059 | |
| Disease | Cirrhosis | 8.48e-05 | 50 | 50 | 3 | C1623038 | |
| Disease | Pneumonia | 1.07e-04 | 54 | 50 | 3 | C0032285 | |
| Disease | Pneumonitis | 1.07e-04 | 54 | 50 | 3 | C3714636 | |
| Disease | Lobar Pneumonia | 1.07e-04 | 54 | 50 | 3 | C0032300 | |
| Disease | Experimental Lung Inflammation | 1.07e-04 | 54 | 50 | 3 | C0887898 | |
| Disease | factor VIII deficiency (is_implicated_in) | 1.53e-04 | 11 | 50 | 2 | DOID:12134 (is_implicated_in) | |
| Disease | pulmonary emphysema (is_implicated_in) | 1.53e-04 | 11 | 50 | 2 | DOID:9675 (is_implicated_in) | |
| Disease | cystic fibrosis (is_marker_for) | 1.61e-04 | 62 | 50 | 3 | DOID:1485 (is_marker_for) | |
| Disease | chronic obstructive pulmonary disease (is_implicated_in) | 1.69e-04 | 63 | 50 | 3 | DOID:3083 (is_implicated_in) | |
| Disease | epilepsy (implicated_via_orthology) | 1.70e-04 | 163 | 50 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Centriacinar Emphysema | 1.84e-04 | 12 | 50 | 2 | C0221227 | |
| Disease | Panacinar Emphysema | 1.84e-04 | 12 | 50 | 2 | C0264393 | |
| Disease | Focal Emphysema | 1.84e-04 | 12 | 50 | 2 | C2350878 | |
| Disease | lung disease (implicated_via_orthology) | 2.17e-04 | 13 | 50 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | Anemia, Hemolytic, Acquired | 2.17e-04 | 13 | 50 | 2 | C0002879 | |
| Disease | Anemia, Hemolytic | 2.17e-04 | 13 | 50 | 2 | C0002878 | |
| Disease | Anemia, Microangiopathic | 2.17e-04 | 13 | 50 | 2 | C0002889 | |
| Disease | Microangiopathic hemolytic anemia | 2.17e-04 | 13 | 50 | 2 | C0221021 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 2.51e-04 | 72 | 50 | 3 | DOID:9744 (is_marker_for) | |
| Disease | sickle cell anemia (is_marker_for) | 2.53e-04 | 14 | 50 | 2 | DOID:10923 (is_marker_for) | |
| Disease | Diabetic Asymmetric Polyneuropathy | 2.53e-04 | 14 | 50 | 2 | C0393835 | |
| Disease | Diabetic Neuralgia | 2.53e-04 | 14 | 50 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 2.53e-04 | 14 | 50 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 2.53e-04 | 14 | 50 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 2.53e-04 | 14 | 50 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 2.53e-04 | 14 | 50 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 2.53e-04 | 14 | 50 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 2.53e-04 | 14 | 50 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 2.53e-04 | 14 | 50 | 2 | C0271680 | |
| Disease | migraine disorder | 3.42e-04 | 357 | 50 | 5 | MONDO_0005277 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 3.77e-04 | 17 | 50 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | Pulmonary Emphysema | 3.77e-04 | 17 | 50 | 2 | C0034067 | |
| Disease | Uremia | 3.77e-04 | 17 | 50 | 2 | C0041948 | |
| Disease | carotid artery disease (is_marker_for) | 4.72e-04 | 19 | 50 | 2 | DOID:3407 (is_marker_for) | |
| Disease | inflammatory bowel disease (is_implicated_in) | 4.72e-04 | 19 | 50 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | Lung Injury | 5.79e-04 | 21 | 50 | 2 | C0273115 | |
| Disease | Chronic Lung Injury | 5.79e-04 | 21 | 50 | 2 | C2350344 | |
| Disease | impotence (biomarker_via_orthology) | 6.36e-04 | 22 | 50 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | myocardial infarction (is_implicated_in) | 6.40e-04 | 99 | 50 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | coronary artery disease (is_implicated_in) | 6.59e-04 | 100 | 50 | 3 | DOID:3393 (is_implicated_in) | |
| Disease | Acute Kidney Insufficiency | 6.79e-04 | 101 | 50 | 3 | C1565662 | |
| Disease | Acute kidney injury | 6.79e-04 | 101 | 50 | 3 | C2609414 | |
| Disease | Kidney Failure, Acute | 6.79e-04 | 101 | 50 | 3 | C0022660 | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 6.96e-04 | 23 | 50 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | brain ischemia (biomarker_via_orthology) | 6.99e-04 | 102 | 50 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Septicemia | 7.58e-04 | 24 | 50 | 2 | C0036690 | |
| Disease | Sepsis | 7.58e-04 | 24 | 50 | 2 | C0243026 | |
| Disease | Severe Sepsis | 7.58e-04 | 24 | 50 | 2 | C1719672 | |
| Disease | Pyemia | 7.58e-04 | 24 | 50 | 2 | C0034189 | |
| Disease | interstitial lung disease (is_marker_for) | 8.23e-04 | 25 | 50 | 2 | DOID:3082 (is_marker_for) | |
| Disease | atopic dermatitis (is_implicated_in) | 8.91e-04 | 26 | 50 | 2 | DOID:3310 (is_implicated_in) | |
| Disease | anogenital venereal wart (is_marker_for) | 8.91e-04 | 26 | 50 | 2 | DOID:11168 (is_marker_for) | |
| Disease | acute kidney failure (implicated_via_orthology) | 9.61e-04 | 27 | 50 | 2 | DOID:3021 (implicated_via_orthology) | |
| Disease | Hyperplasia | 1.03e-03 | 28 | 50 | 2 | C0020507 | |
| Disease | pneumonia (is_marker_for) | 1.03e-03 | 28 | 50 | 2 | DOID:552 (is_marker_for) | |
| Disease | Developmental Academic Disorder | 1.11e-03 | 29 | 50 | 2 | C1330966 | |
| Disease | Learning Disorders | 1.11e-03 | 29 | 50 | 2 | C0023186 | |
| Disease | Learning Disturbance | 1.11e-03 | 29 | 50 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 1.11e-03 | 29 | 50 | 2 | C0751262 | |
| Disease | Learning Disabilities | 1.11e-03 | 29 | 50 | 2 | C0751265 | |
| Disease | cardiovascular age measurement | 1.11e-03 | 29 | 50 | 2 | EFO_0803380 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.19e-03 | 30 | 50 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | Adult T-Cell Lymphoma/Leukemia | 1.27e-03 | 31 | 50 | 2 | C0023493 | |
| Disease | asthma (is_marker_for) | 1.29e-03 | 126 | 50 | 3 | DOID:2841 (is_marker_for) | |
| Disease | hypertension (implicated_via_orthology) | 1.35e-03 | 128 | 50 | 3 | DOID:10763 (implicated_via_orthology) | |
| Disease | Cholestasis, Extrahepatic | 1.35e-03 | 32 | 50 | 2 | C0005398 | |
| Disease | pulmonary sarcoidosis (is_marker_for) | 1.35e-03 | 32 | 50 | 2 | DOID:13406 (is_marker_for) | |
| Disease | Behcet's disease (is_marker_for) | 1.44e-03 | 33 | 50 | 2 | DOID:13241 (is_marker_for) | |
| Disease | Chronic Obstructive Airway Disease | 1.44e-03 | 33 | 50 | 2 | C0024117 | |
| Disease | Chronic Airflow Obstruction | 1.44e-03 | 33 | 50 | 2 | C1527303 | |
| Disease | Global developmental delay | 1.50e-03 | 133 | 50 | 3 | C0557874 | |
| Disease | IGA Glomerulonephritis | 1.52e-03 | 34 | 50 | 2 | C0017661 | |
| Disease | daytime rest measurement | 1.57e-03 | 295 | 50 | 4 | EFO_0007828 | |
| Disease | type 2 diabetes mellitus (is_marker_for) | 1.60e-03 | 136 | 50 | 3 | DOID:9352 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFHMYLALVKVFNTY | 716 | Q8IZP9 | |
| VHFCKLIFAIYKMSF | 126 | P32248 | |
| YKQVLDTYMFHSFLK | 401 | A2RUS2 | |
| VGKVYAALMIFDFYK | 1851 | Q00975 | |
| YLFTLAYEKMHQFYK | 931 | Q96F81 | |
| YAFVMFKTLKDYNTA | 326 | Q8IXT5 | |
| MEHVIYSVKFFISYA | 841 | Q4KMQ2 | |
| YKNVMLFFAKGKFYH | 366 | Q7Z418 | |
| VFFTLHIYQYRMEKS | 681 | Q2KJY2 | |
| GMKAFVSYVQAYAKH | 421 | Q8NHQ9 | |
| VLKDFYVHTVMTCYF | 966 | Q63HM2 | |
| VYHYQMKIHVFSYKN | 346 | Q9Y5X9 | |
| YFYILFTIFTMKSKE | 216 | A6NET4 | |
| FYLTDRVMTVSFHKY | 181 | O15379 | |
| LTHFVRFFLMFYKEK | 301 | A6NG13 | |
| QFLKLDYFQKLYMHS | 261 | O95522 | |
| LFKKYSFMAVIHFAG | 76 | Q14376 | |
| FICKFIHYFFTVSML | 106 | P47211 | |
| RHKCINFFVKVYGYM | 876 | O43909 | |
| VVIYHGMSALQKKYY | 276 | Q86WJ1 | |
| IFLHEFSMAYTKYVG | 1506 | Q9Y4F3 | |
| IYFTMESLKQIHFLY | 3811 | Q14204 | |
| GFKLVMASLYHIYVA | 46 | P09601 | |
| MLFSAFEKHQYYNLK | 186 | P13984 | |
| EYKFQYAYFRMGIKH | 231 | Q7Z6M4 | |
| FIYFFACKGYKRKVM | 306 | P32249 | |
| KVLLEYADKMFTYVF | 1236 | Q14524 | |
| FCETKKAYFLGYMVH | 356 | P30876 | |
| HLKNFDMVIVYKDYS | 851 | Q9Y5B9 | |
| VTYYHYFSKMKALAV | 271 | Q01082 | |
| EEFIHYLKYVMVVYK | 46 | Q9BPX3 | |
| YHIFFDKVFTSVKLM | 346 | Q6P3X8 | |
| HMKYSILPDYYKFIV | 66 | Q86X19 | |
| YYSLIKMVFAAAKAS | 2956 | Q63HN8 | |
| MKFFFKRYLDYEKQH | 1831 | Q14690 | |
| FLHSFTMYKLYQKLF | 371 | O00300 | |
| ENGRFAKYKYFTHVM | 3066 | Q96RL7 | |
| DFYYFMAKIFIHKGR | 136 | Q96MH6 | |
| YYHYFSKMKALAVEG | 276 | O15020 | |
| KEMVFFLFAKHYLFC | 191 | A6NEH6 | |
| YDKFKQSTHSIYMFF | 121 | P01137 | |
| VLTFAYKHALVNKMY | 1181 | P29144 | |
| IFFTEYKYHITKIVM | 196 | P53804 | |
| SFLDKMSFYNELYKH | 466 | Q5SRE5 | |
| YVVSFYHYFSKMKAL | 276 | Q9H254 | |
| IITYVVAFYHYFSKM | 266 | P11277 | |
| VAFYHYFSKMKVLAV | 271 | P11277 | |
| GKFFYVKAYLMVHQK | 236 | P17030 | |
| QSKMYHCDIYVKVFY | 141 | Q86V71 | |
| IVFAYFYMVVKKCFK | 1016 | Q7Z2W7 | |
| VVAVLVYKFYFHLML | 646 | O00206 | |
| MVADVFSHRFYKLYQ | 541 | P51784 | |
| TYEKFLHRYKMISEF | 631 | O94832 |